Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Genprex (GNPX) stock

Learn how to easily invest in Genprex stock.

Genprex, Inc
-$0.17 (-5.26%)

Genprex, Inc is a biotechnology business based in the US. Genprex shares (GNPX) are listed on the NASDAQ and all prices are listed in US Dollars. Genprex employs 12 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Genprex

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GNPX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Genprex stock price (NASDAQ: GNPX)

Use our graph to track the performance of GNPX stocks over time.

Genprex shares at a glance

Information last updated 2021-07-23.
Latest market close$3.74
52-week range$2.80 - $7.72
50-day moving average $3.40
200-day moving average $4.22
Wall St. target price$6.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.76

Buy Genprex shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
$0 per year
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Genprex stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Genprex price performance over time

Historical closes compared with the close of $3.74 from 2021-05-28

1 week (2021-07-14) N/A
1 month (2021-06-25) 4.18%
3 months (2021-04-21) N/A
6 months (2021-01-21) N/A
1 year (2020-07-21) N/A
2 years (2019-07-21) N/A
3 years (2018-07-21) N/A
5 years (2016-07-21) N/A

Genprex financials

Gross profit TTM $0
Return on assets TTM -31.18%
Return on equity TTM -50.74%
Profit margin 0%
Book value $1.07
Market capitalisation $153 million

TTM: trailing 12 months

Shorting Genprex shares

There are currently 2.8 million Genprex shares held short by investors – that's known as Genprex's "short interest". This figure is 24.8% down from 3.7 million last month.

There are a few different ways that this level of interest in shorting Genprex shares can be evaluated.

Genprex's "short interest ratio" (SIR)

Genprex's "short interest ratio" (SIR) is the quantity of Genprex shares currently shorted divided by the average quantity of Genprex shares traded daily (recently around 762319.3989071). Genprex's SIR currently stands at 3.66. In other words for every 100,000 Genprex shares traded daily on the market, roughly 3660 shares are currently held short.

However Genprex's short interest can also be evaluated against the total number of Genprex shares, or, against the total number of tradable Genprex shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Genprex's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Genprex shares in existence, roughly 60 shares are currently held short) or 0.0701% of the tradable shares (for every 100,000 tradable Genprex shares, roughly 70 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Genprex.

Find out more about how you can short Genprex stock.

Genprex share dividends

We're not expecting Genprex to pay a dividend over the next 12 months.

Genprex share price volatility

Over the last 12 months, Genprex's shares have ranged in value from as little as $2.8 up to $7.72. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Genprex's is -0.9292. This would suggest that Genprex's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Genprex has bucked the trend.

Genprex overview

Genprex, Inc. , a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes who currently have limited treatment options. The company works with institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Its lead product candidate is REQORSA (GPX-001), which is in preclinical stage for the treatment of non-small cell lung cancer (NSCLC). It is also developing GPX-002, a preclinical stage gene therapy for diabetes. The company also offers ONCOPREX, a nanoparticle delivery system.

Stocks similar to Genprex

Genprex in the news

There are no recent company news

Frequently asked questions

What percentage of Genprex is owned by insiders or institutions?
Currently 10.551% of Genprex shares are held by insiders and 17.436% by institutions.
How many people work for Genprex?
Latest data suggests 12 work at Genprex.
When does the fiscal year end for Genprex?
Genprex's fiscal year ends in December.
Where is Genprex based?
Genprex's address is: Health Discovery Building, Austin, TX, United States, 78712-1885
What is Genprex's ISIN number?
Genprex's international securities identification number is: US3724461047
What is Genprex's CUSIP number?
Genprex's Committee on Uniform Securities Identification Procedures number is: 372446104

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site